share_log

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket

Benzinga ·  Jun 21 20:22

Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA approval of ELEVIDYS to Duchenne Muscular Dystrophy patients ages 4 and above.

Sarepta Therapeutics shares climbed 35.2% to $166.96 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Spectaire Holdings Inc (NASDAQ:SPEC) rose 110% to $0.7140 in pre-market trading after the company announced a purchase order and delivery of its advanced AireCore units to American Ag Energy.
  • DermTech, Inc. (NASDAQ:DMTK) gained 105.5% to $0.2423 in pre-market trading after declining 19% on Thursday. DermTech recently filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
  • Trinity Place Holdings Inc. (NYSE:TPHS) shares rose 35.7% to $0.1740 in pre-market trading after gaining more than 5% on Thursday.
  • Barinthus Biotherapeutics PLC – ADR (NASDAQ:BRNS) shares rose 25.5% to $1.57 in pre-market trading after dipping 26% on Thursday.
  • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) rose 22.5% to $0.1791 in pre-market trading. Zoomcar announced closing of sale of $3.6 million notes private placement.
  • Ondas Holdings Inc. (NASDAQ:ONDS) gained 16.6% to $0.77 in pre-market trading after declining around 10% on Thursday.
  • Lion Group Holding Ltd – ADR (NASDAQ:LGHL) shares gained 13.1% to $0.44 in pre-market trading.
  • Solid Biosciences Inc (NASDAQ:SLDB) shares rose 11.9% to $7.05 in pre-market trading after falling over 7% on Thursday.
  • Clover Health Investments, Corp. (NASDAQ:CLOV) shares climbed 7.8% to $1.11 in pre-market trading following insider buying from the company's co-founder. After the market close on Thursday, Clover Health filed a Form 4 with the SEC showing that co-founder and executive chair Vivek Garipalli purchased 877,567 shares of Clover Health stock at an average price of $1.14 per share.

Losers

  • Psyence Biomedical Ltd. (NASDAQ:PBM) shares fell 23.6% to $0.4547 in pre-market trading after gaining 6% on Thursday.
  • Professional Diversity Network, Inc. (NASDAQ:IPDN) shares fell 21.1% to $0.5102 in pre-market trading after dipping around 14% on Thursday.
  • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares declined 18.5% to $0.1310 in pre-market trading after gaining 35% on Thursday.
  • Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 17.6% to $0.4544 in pre-market trading.
  • Reliance Global Group, Inc. (NASDAQ:RELI) shares fell 16.8% to $0.5021 in pre-market trading. Reliance Global shares jumped 54% on Thursday after the company announced an institutional investor has redeemed all of its outstanding Series B and Series G warrants.
  • MGO Global, Inc. (NASDAQ:MGOL) fell 16% to $0.6296 in pre-market trading. MGO Global shares jumped 63% on Thursday after the company and Heidmar entered an agreement for a business combination.
  • Trevena, Inc. (NASDAQ:TRVN) shares declined 13.1% to $0.2138 in pre-market trading after dipping over 30% on Thursday. Trevena announced preclinical TRV045 data for long-term analgestic effect in prelinical model of neuropathic pain.
  • Molecular Partners AG (NASDAQ:MOLN) shares dipped 12.7% to $9.61 in pre-market trading after jumping over 38% on Thursday.
  • NANO Nuclear Energy Inc. (NASDAQ:NNE) shares fell 9.7% to $13.74 in pre-market trading after surging 31% on Thursday.
  • VinFast Auto Ltd. (NASDAQ:VFS) fell 7.9% to $3.97 in pre-market trading after gaining 10% on Thursday.

Now Read This: Top 4 Consumer Stocks that May Keep You Up At Night This Month

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment